Literature DB >> 8142794

Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Trent Regional Hepatitis C Virus Study Group.

W L Irving1, K R Neal, J C Underwood, P N Simmonds, V James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8142794      PMCID： PMC2539416          DOI： 10.1136/bmj.308.6930.695

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Improvement of HCV genome detection with "short" PCR products.

Authors:  J A Garson; C J Ring; P W Tuke
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

2.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

3.  Use of anti-GOR testing in the screening of blood donors for hepatitis C virus infection.

Authors:  W L Irving; S Day; D Bennett; R P Eglin; P Flanagan; P Nuttall; V James
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

4.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

5.  A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs.

Authors:  M Makris; F E Preston; D R Triger; J C Underwood; L Westlake; M I Adelman
Journal:  Blood       Date:  1991-10-01       Impact factor: 22.113
  5 in total
  11 in total

1.  Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity.

Authors:  D J Mutimer; R F Harrison; K B O'Donnell; J Shaw; B A Martin; H Atrah; F A Ala; S Skidmore; S G Hubscher; J M Neuberger
Journal:  BMJ       Date:  1994-10-01

Review 2.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  The epidemiology of hepatitis C in a UK health regional population of 5.12 million.

Authors:  A H Mohsen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Asymptomatic hepatitis C infection. Be cautious with liver biopsy.

Authors:  R Valori; J Christie
Journal:  BMJ       Date:  1994-05-07

5.  Testing healthcare staff for infection with HIV and hepatitis: logistic and ethical considerations.

Authors:  A Newell; S E Barton
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

6.  Asymptomatic infection with hepatitis C virus.

Authors:  C A Seymour
Journal:  BMJ       Date:  1994-03-12

7.  Asymptomatic hepatitis C infection. More questions than answers.

Authors:  C Ford
Journal:  BMJ       Date:  1994-05-07

8.  Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases.

Authors:  C J Healey; R W Chapman; K A Fleming
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

9.  Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases.

Authors:  C-K Hui; A Monto; T Belaye; E Lau; T L Wright
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

10.  Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection.

Authors:  G H Haydon; L M Jarvis; C S Blair; P Simmonds; D J Harrison; K J Simpson; P C Hayes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.